News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Virginia Kaklamani and Sara Tolaney discuss DESTINY-Breast09 trial and ASCENT-04/KEYNOTE-D19 study during SABCS Snippets
SABCS/X
Apr 27, 2025, 10:42

Virginia Kaklamani and Sara Tolaney discuss DESTINY-Breast09 trial and ASCENT-04/KEYNOTE-D19 study during SABCS Snippets

SABCS shared a post on X:

“New SABCS Snippets:
Virginia Kaklamani and Sara Tolaney discuss results from two potentially practice-changing trials that were released this week—the Phase 3 DESTINY-Breast09 trial and the Phase III ASCENT-04/KEYNOTE-D19 study.”

More posts featuring SABCS.

Breast Cancer cancer DESTINY-Breast09 trial OncoDaily Oncology SABCS Sara Tolaney Virginia Kaklamani
Special Coverage
Voices
Sep 2, 2025, 15:45
Preparing NSCLC for the Future of Diagnostic Biomarker Testing - IASCL
Societies
Sep 2, 2025, 15:45
Gold September 2025: Add Your Voice to the SIOPE Virtual Awareness Wall for Paediatric Oncology
Science
Sep 2, 2025, 15:43
Vineet Datta: A Decade Ago I Read Chetan Bettegowda’s Landmark 2014 Study, Now I’m Honored to Collaborate with Him
Voices
Sep 2, 2025, 15:32
Douglas Flora: Beyond the MCAT - Choosing Doctors for an AI Age
Voices
Sep 2, 2025, 15:27
The Dorcas Cancer Foundation Presents PedROC September Series
Voices
Sep 2, 2025, 15:23
Sophie Bussmann-Kemdjo: Turning Ambition Into Action, and Action Into Lasting Systems Change
Voices
Sep 2, 2025, 15:22
Every Child Deserves a Future Free from the Shadows of Cancer - Medicaid Cancer Foundation
Blog Posts
Sep 2, 2025, 15:21
Highlights from Danish Cancer Research Days 2025 - Danish Cancer Institute
Immune Oncology
Sep 2, 2025, 15:16
Top Immunotherapy Trials in Head and Neck and Endocrine Cancers to Watch at ESMO 2025
Voices
Sep 2, 2025, 15:11
Hassan R. Hashmi: A Reminder to Honor the Hard Work and Dedication Across All Fields
Science
Sep 2, 2025, 15:08
Ropeginterferon Redefines Second-Line Therapy in High-Risk Essential Thrombocythemia - Hematology Frontier
Career Updates
Sep 2, 2025, 15:05
Devika Das as New Division Director at the University of Mississippi Medical Center